Diffuse Perfusion Impairment Versus Global Myocardial Flow Reserve and Focal Perfusion Impairments in Patients Undergoing 82 Rb-PET Imaging
Circulation: Cardiovascular Imaging · 2026-05 · 19 (5)
DOI: 10.1161/circimaging.125.019246 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Imaging, 2026-05. Verfasst von Ahmed Sayed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist DeBakey Heart and Vascular Center, TX (A.S., M.A., A.E.Y., M.A.R., M.H.A.-M.). Hauptthemen laut MEDLINE: Myocardial Perfusion Imaging, Positron-Emission Tomography, Rubidium Radioisotopes, Fractional Flow Reserve, Myocardial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Although global myocardial flow reserve (MFR) is a powerful prognostic factor, it may overlook segmental abnormalities and does not differentiate focal from diffuse perfusion impairments. Therefore, we sought to assess whether integrated MFR provides incremental prognostic value beyond global MFR. METHODS: Consecutive patients undergoing positron emission tomography myocardial perfusion imaging between 2019 and 2025 were included. For each patient, global MFR and the proportion of the myocardium with diffuse and focal integrated MFR impairment were quantified. The primary outcome was the total burden of death, myocardial infarction, and heart failure hospitalization. Multivariable Andersen-Gill Cox models with robust variance estimators were used to estimate hazard ratios (HRs). Restricted cubic splines were used to account for potential nonlinearity. RESULTS: Over a median follow-up of 550 days (interquartile range, 203–1017 days), 1511 primary outcome events occurred in 8500 patients. In a multivariable model adjusted for both parameters, diffusely impaired integrated MFR (HR per interquartile range, 2.02 [95% CI, 1.33–3.05]), but not global MFR (HR per interquartile range, 1.10 [95% CI, 0.82–1.47]), was associated with poorer outcomes. Diffuse perfusion impairment was more strongly associated with the primary outcome (HR per interquartile range, 2.20 [95% CI, 1.72–2.82]) than focal impairment (HR, 1.25 [95% CI, 1.07–1.46]). Diffusely impaired integrated MFR was more prognostic in patients with a preserved left ventricular ejection fraction ( P for interaction
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Houston Methodist DeBakey Heart and Vascular Center, TX (A.S., M.A., A.E.Y., M.A.R., M.H.A.-M.).
- Rochester General Hospital, NY (A.S.).
- INVIA Medical Imaging Solutions, Ann Arbor, MI (J.B.M., A.P.-R., J.M.R.).
- University of Michigan, Ann Arbor (V.L.M.).
ORCID-Profile: Ahmed Sayed, Jonathan B Moody, Alexis Poitrasson-Rivière, Jennifer M Renaud, Ahmad El Yaman, Mahmoud Al Rifai, Venkatesh L Murthy, Mouaz H Al-Mallah
Zitieren
APA
Sayed, A., Moody, J. B., Poitrasson-Rivière, A., Renaud, J. M., Alwan, M., El Yaman, A., Al Rifai, M., Murthy, V. L., & Al-Mallah, M. H. (2026). Diffuse Perfusion Impairment Versus Global Myocardial Flow Reserve and Focal Perfusion Impairments in Patients Undergoing 82 Rb-PET Imaging. Circulation: Cardiovascular Imaging, 19(5). https://doi.org/10.1161/circimaging.125.019246
Vancouver
Sayed A, Moody JB, Poitrasson-Rivière A, Renaud JM, Alwan M, El Yaman A, et al. Diffuse Perfusion Impairment Versus Global Myocardial Flow Reserve and Focal Perfusion Impairments in Patients Undergoing 82 Rb-PET Imaging. Circulation: Cardiovascular Imaging. 2026;19(5). doi:10.1161/circimaging.125.019246
BibTeX
@article{Sayed2026,
author = {Sayed, Ahmed and Moody, Jonathan B and Poitrasson-Rivière, Alexis and Renaud, Jennifer M and Alwan, Maria and El Yaman, Ahmad and Al Rifai, Mahmoud and Murthy, Venkatesh L and Al-Mallah, Mouaz H},
title = {Diffuse Perfusion Impairment Versus Global Myocardial Flow Reserve and Focal Perfusion Impairments in Patients Undergoing 82 Rb-PET Imaging},
journal = {Circulation: Cardiovascular Imaging},
year = {2026},
volume = {19},
number = {5},
doi = {10.1161/circimaging.125.019246}
}
EUVIMED